About BioEnTech
BioEnTech is a company based in Lyon (France) founded in 2013 was acquired by SUEZ in October 2022. BioEnTech has raised $7.29 million across 2 funding rounds from investors including Crédit Agricole, SUEZ and Bpifrance. BioEnTech offers products and services including MeMo, IR-SCAN, and SNAC. BioEnTech operates in a competitive market with competitors including Methes Energies International, anessa, Ibk Bioanalytik, BOGIS - Biogas and Tech Vizyon, among others.
- Headquarter Lyon, France
-
Sectors
Energy & Utilities
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.29 M (USD)
in 2 rounds
-
Latest Funding Round
$6.34 M (USD), Series A
Feb 16, 2017
-
Investors
Crédit Agricole
& 5 more
-
Employee Count
Not available
-
Acquired by
SUEZ
(Oct 10, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioEnTech
BioEnTech offers a comprehensive portfolio of products and services, including MeMo, IR-SCAN, and SNAC.
Solution for monitoring and decision support in methanizers.
Evaluates potential yield of organic materials for optimization.
In-situ sensor for simplified methanizer tracking and management.
Funding Insights of BioEnTech
BioEnTech has successfully raised a total of $7.29M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.34 million completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioEnTech
BioEnTech has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Crédit Agricole, SUEZ and Bpifrance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Regional capital investment services are provided by SOFILARO CALEN.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Crédit Agricole is recognized as a leading banking institution in France.
|
Locked | Locked | Locked |
Investor details for BioEnTech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioEnTech
Investment portfolio details for BioEnTech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioEnTech
Detailed financials for BioEnTech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioentech Comparisons
Peer comparison for BioEnTech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioEnTech
BioEnTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Methes Energies International, anessa, Ibk Bioanalytik, BOGIS - Biogas and Tech Vizyon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biodiesel is produced and related technologies are developed internationally.
|
|
| Locked | Locked | Locked |
Software solutions for biogas plant assessment and operations are provided.
|
|
| Locked | Locked | Locked |
Offers software monitoring solutions for biogas plants.
|
|
| Locked | Locked | Locked |
Software for biogas plant management, energy monitoring, and maintenance operations.
|
|
| Locked | Locked | Locked |
Provides software for digital transformation and efficiency in renewable energy operations.
|
Detailed competitors of BioEnTech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioentech
Complete news archive for BioEnTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioEnTech
BioEnTech was founded in 2013 and raised its 1st funding round 3 years after it was founded.
BioEnTech is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
BioEnTech is a funded company, having raised a total of $7.29M across 2 funding rounds to date.
BioEnTech was founded in 2013 and is located in Lyon, France. Operations focus on the bioprocessing sector, where monitoring solutions for biogas plants are developed. The MeMo-pro system centralizes collected data to estimate key process variables and diagnose reactor physiological states in real-time. Disturbances are detected quickly, and corrective actions are proposed to stabilize and optimize processes.
BioEnTech's top competitors include Methes Energies International, anessa and Ibk Bioanalytik.
BioEnTech offers MeMo, IR-SCAN, and SNAC.
BioEnTech has 6 investors. Key investors include Crédit Agricole, SUEZ, Bpifrance, SOFILARO CALEN, and IRDI Soridec Gestion.